Next Article in Journal
A Modified Recommended Food Score Is Inversely Associated with High Blood Pressure in Korean Adults
Next Article in Special Issue
Probiotic Bacillus Spores Together with Amino Acids and Immunoglobulins Exert Protective Effects on a Rat Model of Ulcerative Colitis
Previous Article in Journal
Effect of Probiotic Supplementation on Newborn Birth Weight for Mother with Gestational Diabetes Mellitus or Overweight/Obesity: A Systematic Review and Meta-Analysis

Iron Therapy in Inflammatory Bowel Disease

The Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP, UK
Research Institute in Healthcare Science (RIHS), University of Wolverhampton, Wolverhampton WV1 1LY, UK
Author to whom correspondence should be addressed.
Nutrients 2020, 12(11), 3478;
Received: 1 November 2020 / Revised: 8 November 2020 / Accepted: 10 November 2020 / Published: 12 November 2020
(This article belongs to the Special Issue Nutritional Management for Inflammatory Bowel Diseases)
The most common complication seen in inflammatory bowel disease (IBD) patients is iron deficiency anaemia (IDA). Symptoms such as chronic fatigue can be as debilitating to IBD patients as pathological symptoms of abdominal pain and diarrhoea. Recognising and correcting anaemia may be as important as managing IBD symptoms and improving overall quality of life. Thus, iron replacement should be commenced the moment IDA is identified. Although intravenous iron is now considered standard treatment for IBD patients in Europe, oral iron still appears to be the preferred option. Advantages of oral iron include greater availability, lower costs and ease of applicability. However, its multitude of side effects, impact on the microbiome and further exacerbating IBD activity can have consequences on patient compliance. The newer oral iron formulations show promising safety and efficacy data with a good side effect profile. Intravenous iron formulations bypass the gastrointestinal tract absorption thereby leading to less side effects. Multiple studies have shown its superiority compared to oral formulations although its risk for hypersensitivity reactions continue to lead to clinician hesitancy in prescribing this formulation. This article provides an updated review on diagnosis and management of IDA in IBD patients, discussing the newer oral and intravenous formulations. View Full-Text
Keywords: iron; inflammatory bowel disease; iron therapy; intravenous iron; oral iron; iron deficiency iron; inflammatory bowel disease; iron therapy; intravenous iron; oral iron; iron deficiency
Show Figures

Figure 1

MDPI and ACS Style

Kumar, A.; Brookes, M.J. Iron Therapy in Inflammatory Bowel Disease. Nutrients 2020, 12, 3478.

AMA Style

Kumar A, Brookes MJ. Iron Therapy in Inflammatory Bowel Disease. Nutrients. 2020; 12(11):3478.

Chicago/Turabian Style

Kumar, Aditi, and Matthew J. Brookes. 2020. "Iron Therapy in Inflammatory Bowel Disease" Nutrients 12, no. 11: 3478.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop